1. Screening Libraries
  2. Kinase Inhibitor Library

Kinase Inhibitor Library

(588 bioactive Compounds) Cat. No.: HY-L009
Library Contents: XLSX PDF

A unique collection of 588 kinase inhibitors/regulators for high throughput screening (HTS) and high content screening (HCS).

Size (Pre-dissolved DMSO or Solid) Price Stock
30 μL/well (10 mM solution) Get quote In-stock
50 μL/well (10 mM solution) Get quote In-stock
100 μL/well (10 mM solution) Get quote In-stock
250 μL/well (10 mM solution) Get quote In-stock
Top Publications Citing Use of Products

MCE Screening Library Partners

  • Description

  • Product Details

  • Composition

  • Contents

  • Documentation

Description
& Advantages

•   A unique collection of 588 kinase inhibitors/regulators for high throughput screening (HTS) and high content screening (HCS).

•   Targets kinases such as RTKs, PI3K, Aurora Kinase, CDK, PKC, VEGFR, ROCK and Raf etc.

•   Bioactivity and safety confirmed by preclinical research and clinical trials.

•   Some inhibitors have been approved by the FDA.

•   Most are ATP competitive.

•   Structurally diverse, medicinally active, and cell permeable.

•   Rich documentation with structure, IC50, and customer reviews.

•   NMR and HPLC validated to ensure high purity.

Product Details
Formulation:
A collection of 588 kinase regulators supplied as pre-dissolved DMSO solutions
Container:
96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Storage:
-80°C
Shipping:
Blue ice
Composition

Contents of Kinase Inhibitor Library

Plate layout: HY-L009-1

1 2 3 4 5 6 7 8 9 10 11 12
a Empty MRT68921 (hydrochloride) Flavopiridol Flavopiridol (Hydrochloride) SNS-032 TA-01 AZD-5438 IQ-1S (free acid) GSK583 NVP-BAW2881 PF-04979064 Empty
b Empty AEE788 Y-27632 TPCA-1 Triapine LY294002 AS-605240 IC-87114 TG100-115 TGX-221 PI-103 (Hydrochloride) Empty
c Empty AZD1152-HQPA AZD1152 ZM-447439 Nilotinib Nilotinib (monohydrochloride monohydrate) Tozasertib IMD-0354 MLN8054 Dasatinib Dasatinib (hydrochloride) Empty
d Empty CHIR-99021 Linsitinib NVP-TAE 684 AZD-1480 BMS-754807 Sorafenib Sorafenib (Tosylate) Tandutinib OSI-930 Cediranib Empty
e Empty Amuvatinib Pazopanib Masitinib CUDC-101 Motesanib Motesanib (Diphosphate) Saracatinib BRAF inhibitor GSK-690693 AG1024 Empty
f Empty PD0325901 Sunitinib SB 203580 SB 203580 (hydrochloride) Vandetanib Afatinib Afatinib (dimaleate) BMS-536924 SB 202190 GSK2126458 Empty
g Empty PIK-294 Doramapimod PD173074 BIBX 1382 D4476 CL-387785 VX-745 Toceranib Toceranib (phosphate) Regorafenib Empty
h Empty Regorafenib (monohydrate) Brivanib (alaninate) Brivanib Foretinib KW-2449 KX2-391 (dihydrochloride) Fasudil (Hydrochloride) Enzastaurin Sotrastaurin AZD 6482 Empty

Plate layout: HY-L009-2

1 2 3 4 5 6 7 8 9 10 11 12
a Empty AKT inhibitor VIII MK 2206 BI-78D3 Canertinib (dihydrochloride) Pim1/AKK1-IN-1 PP121 SU5416 VX-702 Losmapimod SCIO-469 Empty
b Empty SU 5402 Ki20227 TG-101348 TG101209 PHA-848125 TAK-715 PF-562271 (besylate) PF-573228 Dinaciclib BMS-794833 Empty
c Empty SU14813 SU14813 (maleate) BI-D1870 AR-A014418 BX795 TSU-68 BMS-345541 BMS-345541 (free base) CGP 57380 GSK1904529A Empty
d Empty Telatinib GW 5074 PD 169316 Pluripotin BIO Y-27632 (dihydrochloride) TWS119 Ro 28-1675 PKI-402 EG00229 Empty
e Empty CCT 137690 GW2580 GNF-7 CYT387 CYT387 (sulfate salt) SB-590885 Alisertib Tivozanib Lenvatinib ENMD-2076 (Tartrate) Empty
f Empty ENMD-2076 MGCD-265 analog AZD-7762 MK-1775 PCI-32765 Trametinib Trametinib (DMSO solvate) GSK429286A PHA-793887 CP-466722 Empty
g Empty GW843682X AZ 628 BX-912 KU-57788 GNF-2 CGP60474 TDZD-8 WHI-P97 SB 239063 PI3K inhibitor X Empty
h Empty BIBF 1120 (esylate) PHA-665752 R406 (free base) CGI-1746 AG-490 SNS-314 Erlotinib (Hydrochloride) Pazopanib (Hydrochloride) BMS-599626 (Hydrochloride) SB 216763 Empty

Plate layout: HY-L009-3

1 2 3 4 5 6 7 8 9 10 11 12
a Empty PD153035 (Hydrochloride) SU11274 KU-55933 PF-04217903 PF-04217903 (methanesulfonate) Vatalanib SGX-523 WZ4002 PD98059 PIK-90 Empty
b Empty U0126 AMG-208 GSK1059615 Rigosertib (sodium) Ki8751 SP600125 AS703026 Cabozantinib (S-malate) HMN-214 PIK-93 Empty
c Empty Ponatinib Chelerythrine Chloride CCT129202 CP-673451 Hesperadin BIX02188 BIX02189 Vemurafenib AT7867 AT7867 (dihydrochloride) Empty
d Empty KRN-633 KU-60019 PD318088 PHT-427 R406 PI3K-IN-1 DPH LDN193189 LDN193189 (Hydrochloride) Lck Inhibitor Empty
e Empty BMS 777607 Poloxin Volasertib TAK-901 PF-06463922 PI-3065 CID755673 DMH-1 ML347 FR 180204 Empty
f Empty AZ191 K02288 MLN1117 Defactinib IM-12 WH-4-023 Kenpaullone AZD8186 KRCA-0008 HTH-01-015 Empty
g Empty UNC2025 UNC2025 (hydrochloride) Y15 Decernotinib LY-2584702 (tosylate salt) LDC1267 ISRIB (trans-isomer) ANA-12 SKF-86002 LY3023414 Empty
h Empty Bikinin Ro-3306 LY3009120 ZM39923 (hydrochloride) URMC-099 ON123300 Acalisib Entrectinib GNE-317 BLZ945 Empty

Plate layout: HY-L009-4

1 2 3 4 5 6 7 8 9 10 11 12
a Empty IC261 L-779450 Vps34-IN-1 BLU9931 Brigatinib AZD-8835 AMG319 TP-0903 SGI-7079 Quizartinib Empty
b Empty PF-3758309 CH5424802 CH5424802 (Hydrochloride) Cabozantinib MRT67307 GSK1838705A CC-401 (hydrochloride) DCC-2036 CAL-101 CDK-IN-2 Empty
c Empty LY2784544 R788 (disodium hexahydrate) Cediranib (maleate) Sapitinib IKK-2 inhibitor VIII Cobimetinib E-7050 CHIR-98014 NVP-TAE 226 Crenolanib Empty
d Empty YM-201636 CDK9-IN-1 LY2228820 GDC-0980 MK-5108 AMG 900 OSI-420 Thiazovivin NVP-BHG712 CCT128930 Empty
e Empty A66 CHIR-124 Dacomitinib IRAK inhibitor 1 IRAK inhibitor 2 IRAK inhibitor 6 PIK-75 SGI-1776 KN-62 SR-3677 Empty
f Empty LY2874455 Regorafenib (Hydrochloride) NVP-BGJ398 JNK-IN-8 ASP3026 IRAK-1-4 Inhibitor I AZD4547 NVP-BGT226 Apatinib ZM 336372 Empty
g Empty INCB28060 AICAR Dorsomorphin (dihydrochloride) TAK-733 BAY 11-7082 CID 2011756 PHA-767491 (hydrochloride) ALK-IN-1 GNF-5837 Mubritinib Empty
h Empty Piceatannol Nocodazole SB-505124 AG-1478 CAY10505 AS-252424 AZM475271 PQ401 IKK 16 R1530 Empty

Plate layout: HY-L009-5

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Zoledronic acid (monohydrate) ZM 306416 SC-514 PP1 PP2 MK-8745 GSK2656157 SKI II PLX647 PF-4989216 Empty
b Empty Ro 31-8220 (mesylate) WHI-P154 CNX-2006 GDC-0032 VE-822 Flumatinib Flumatinib (mesylate) TCS 359 Hydroxyfasudil (hydrochloride) PND-1186 Empty
c Empty 1-Naphthyl PP1 1-Naphthyl PP1 (hydrochloride) 1-NM-PP1 CNX-774 SKLB1002 BML-277 SRPIN340 DDR1-IN-1 B-Raf inhibitor 1 VX-11e Empty
d Empty PD153035 TBB PDK1 inhibitor XMD8-92 PF-03814735 Genistein Dabrafenib Dabrafenib (Mesylate) CP-724714 Reversine Empty
e Empty CCT241533 (hydrochloride) LY2603618 EMD-1214063 VE-821 AS 602801 Tideglusib R1487 (Hydrochloride) GSK2334470 BAY 61-3606 (dihydrochloride) AST 487 Empty
f Empty NG 52 SBE13 (Hydrochloride) TAK-960 Ro3280 Icotinib (Hydrochloride) SB1317 BEZ235 (Tosylate) PF-04691502 NVP-BKM120 (Hydrochloride) GDC-0068 (dihydrochloride) Empty
g Empty GSK 650394 EMD638683 TAK-285 CEP-32496 MEK162 CHR-6494 c-Kit-IN-1 NVP-LCQ195 BYL-719 GSK2636771 Empty
h Empty MLN 2480 XL413 (hydrochloride) BMS-265246 AIM-100 CZC24832 WP1066 Baricitinib Baricitinib (phosphate) PRT062607 (Hydrochloride) TG003 Empty

Plate layout: HY-L009-6

1 2 3 4 5 6 7 8 9 10 11 12
a Empty CVT-313 CEP-33779 BAY 80-6946 ALK inhibitor 2 5-Iodotubercidin AZD5363 SL327 SB 415286 NVP-BVU972 Triciribine Empty
b Empty SAR131675 Imatinib CH5132799 ZM323881 (hydrochloride) MLN120B TTP 22 PF-670462 AXL1717 JANEX-1 Tyrphostin A9 Empty
c Empty CGK733 ETP-46464 kb NB 142-70 DMAT FRAX486 AZ20 SSR128129E AZD1208 AZD-3463 GDC-0623 Empty
d Empty TIC10 isomer TIC10 AG 18 LDK378 LDK378 (dihydrochloride) IPA-3 XMD17-109 GZD824 LH846 NU 7026 Empty
e Empty Afuresertib Afuresertib (hydrochloride) CO-1686 CO-1686 (hydrobromide) Poziotinib GNF-5 XL228 RKI-1447 AZD2858 A 419259 (trihydrochloride) Empty
f Empty TAK-632 ONO-4059 AZD-9291 AZD-9291 (mesylate) PF-4708671 LEE011 LEE011 (succinate) K145 (hydrochloride) UNC2881 WZ4003 Empty
g Empty VRT752271 NMS-1286937 ID-8 LDC000067 TCS JNK 5a AMG 925 LDN-212854 SAR245409 GSK2141795 GS-9973 Empty
h Empty H-89 (dihydrochloride) Cerdulatinib AZD7545 JI-101 APTO-253 LY2090314 LY2835219 XL-147 TCS-PIM-1-4a VS-5584 Empty

Plate layout: HY-L009-7

1 2 3 4 5 6 7 8 9 10 11 12
a Empty CNX-1351 ZLN024 (hydrochloride) LDN-214117 Pexidartinib Solcitinib Sitravatinib CC-115 CC-115 (hydrochloride) Duvelisib Duvelisib (R enantiomer) Empty
b Empty Acalabrutinib PS-1145 LFM-A13 AVL-292 CEP-28122 (mesylate salt) GSK2606414 TCS PIM-1 1 CX-6258 AZD2932 SKLB610 Empty
c Empty Purvalanol B Purvalanol A GLPG0634 SB 242235 GW 441756 FIIN-2 PD158780 SU9516 Ro 5126766 Centrinone Empty
d Empty Centrinone-B CPDA AMG-337 c-Met inhibitor 2 SC79 AZD3759 ONO-4059 (analog) CCT245737 TAS-301 Anisomycin Empty
e Empty 3-Methyladenine NU2058 AZD6738 Compound 401 Peficitinib MCB-613 Tauroursodeoxycholate (Sodium) LJH685 LJI308 Olmutinib Empty
f Empty Indirubin-3'-monoxime SC66 Fruquintinib CH5183284 GDC-0941 (dimethanesulfonate) Roscovitine Pelitinib Neratinib Tofacitinib (citrate) GDC-0941 Empty
g Empty CI-1040 AT9283 A-769662 BEZ235 JNJ-38877605 Tivantinib BI 2536 Selumetinib Linifanib Palbociclib Empty
h Empty Palbociclib (hydrochloride) ZSTK474 CX-4945 CX-4945 (sodium salt) Ruxolitinib Ruxolitinib (phosphate) GDC-0879 Bafetinib GSK461364 Crizotinib Empty

Plate layout: HY-L009-8

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Crizotinib (hydrochloride) Gefitinib Gefitinib (hydrochloride) Erlotinib Lapatinib Lapatinib (ditosylate) BIBF 1120 Dovitinib Perifosine AT7519 (trifluoroacetate) Empty
b Empty AT7519 (Hydrochloride) Imatinib (Mesylate) PLX-4720 GSK-1070916 Aurora A inhibitor I NVP-BKM120 MNS AZD-9291 (dimesylate) THZ1 THZ1 (Hydrochloride) Empty
c Empty Palbociclib (isethionate) Ellagic acid Amlexanox LY2409881 SU6656 AZ-5104 Scopoletin Scutellarein Empty Empty Empty
d Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
e Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
f Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
g Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
h Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
View More Collapse
Documentation

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number

 

Organization name *

Country *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Kinase Inhibitor Library
Cat. No.:
HY-L009
Quantity:

Request SDF File

Please enter your email address. We will send your requested SDF file to you as soon as possible.